Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Request for Information for Countering Weapons of Mass Destruction (CWMD) OTA

Active
W15QKN18ZTACDFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The amendment attaches a Q&A document to a Request for Information (RFI) issued by the Joint Program Executive Office for Chemical and Biological Defense, specifically the Joint Project Manager Guardian. The RFI seeks input from members of the Countering Weapons of Mass Destruction Consortium regarding their capabilities to provide a Tactical Disablement System Family of Systems. This system is intended to offer tactical disablement capabilities to neutralize or destroy small quantities of chemical and biological materials in munitions and containers, functioning effectively in hostile environments. The goal is to develop a new capability within the Chemical Biological, Radiological, and Nuclear defense enterprise, and the information gathered will influence the acquisition strategy for the system. Responses to the RFI are required by April 16, 2018, and should be submitted via email with specific formatting instructions provided. Marketing or advertising materials are discouraged. Should a solicitation follow based on this RFI, the preferred acquisition method is anticipated to be the Combating Weapons of Mass Destruction Other Transaction Agreement. The solicitation is associated with the Department of Defense at Picatinny Arsenal, New Jersey, under NAICS code 541714, with Emily A. Pellegrino identified as a point of contact.

General Info

RFI seeks Consortium input on Tactical Disablement System for chemical, biological threat response by April 16, 2018.

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

NJ

Set-Aside

NONE

Documents

2

Q&A - 10 April 2018

DOC, Low priority1 page · q-and-a
Low

TacDS Request for Information (RFI)

DOCX, Low priority9 pages · rfi
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update
Posted

special-notice

Notice updated

The notice description changed.

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → W6QK Acc-Pica
Contacts1 person available
OfficePICATINNY ARSENAL, NJ, 07806-5000, USA
Office AddressPICATINNY ARSENAL, NJ, 07806-5000, USA
Contacts
Emily A. Pellegrino

Full Description

Show more
AMENDMENT 01 - The purpose of this amendment is to attach a Q&A Document. Tactical Disablement System (TacDS) Request for Information (RFI) The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), Joint Project Manager Guardian (JPM G) seeks to develop a Tactical Disablement System (TacDS) Family of system (FoS). The TacDS FoS will provide a suite of tactical disablement capabilities that disable (delay, disrupt, and/or degrade) or defeat (destroy) small quantities of Chemical/Biological Materials of Concern (CBMOC) contained in munitions and bulk containers and are able to be used in a hostile environment. The TacDS is a new capability area for the Chemical Biological, Radiological, and Nuclear (CBRN) Enterprise. The JPM G is requesting additional information from the Countering Weapons of Mass Destruction (CWMD) Consortium members on their ability to provide TacDS FoS. The JPM G will use the information acquired from this RFI to optimize the TacDS FoS acquisition strategy. Please see the attachment for additional details. For questions please contact both Richard (Dick) Eichholtz at richard.l.eichholtz.civ@mail.mil and Keyonna Hogan at keyonna.l.hogan.civ@mail.mil. All written responses must be received by COB on 16 April 2018. Responses shall be sent by e-mail to: CWMD-contracts@ati.org, with Subject Line of Responding Organization and RFI Title. Material that is advertisement or marketing in nature is not desired. If a solicitation is subsequently released based on the responses to this RFI the first choice for an acquisition vehicle, if appropriate, will be the Combating Weapons of Mass Destruction (CWMD) Other Transaction Agreement (OTA).

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Grant
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
Solicitation # RFA-AI-28-012
The National Institute of Allergy and Infectious Diseases (NIAID) has issued solicitation RFA-AI-28-012 to establish a consortium of Translational Centers Using Microphysiological Systems for Infectious Diseases (TCMID). The primary objective is to refine and validate human tissue models using Microphysiological Systems (MPS) to a level consistent with regulatory qualifications, thereby promoting their adoption by product developers and reducing reliance on laboratory animals. This initiative aligns with NIH and FDA guidance on New Approach Methodologies (NAMs) to accelerate the development of safer medical interventions by capturing human variability and patient-specific characteristics. The program is structured around an Administrative Core, a Qualification Core, and Scientific Cores, with a heavy emphasis on technical readiness, reproducibility, and regulatory acceptance. Key deliverables include the validation of assays for specific endpoints and the submission of regulatory packages. Applicants must be domestic entities, as foreign organizations and foreign subawards are strictly prohibited. Required personnel must possess deep expertise in infectious diseases, MPS platforms, bioinformatics, and FDA submission processes. Applications are due by January 29, 2027, and must be submitted via the NIH ASSIST system or approved institutional system-to-system solutions. Evaluation is based on an overall impact score considering the project's significance, the suitability of the investigators, and the quality of the institutional environment. Mandatory application components include a Data Management and Sharing Plan and a Benchmarks and Timeline PDF not exceeding six pages. Awardees must also adhere to strict cybersecurity incident reporting guidelines, notifying HHS within 48 hours of any discovery.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

in 3 months
View Details
NAICS: 541714
New
Grant
Immune Tolerance Network (UM1 Clinical Trial Required)
Solicitation # RFA-AI-28-005
The National Institutes of Health, under the Department of Health and Human Services, is seeking applications through solicitation RFA-AI-28-005 to continue the Immune Tolerance Network (ITN). This cooperative agreement aims to develop tolerogenic therapies for immune-mediated disorders, specifically focusing on autoimmune diseases, allergic diseases and asthma, and the immune-mediated consequences of transplantation. The network operates through four integrated functional areas: Leadership, Clinical Operations, Core Laboratory, and Bioinformatics. Its primary objectives include designing and conducting clinical trials, performing integrated mechanistic studies, and sharing research results. Eligible applicants include small businesses and other for-profit organizations, though non-domestic entities are ineligible. Applications are evaluated based on scientific and technical merit, with a primary focus on significance and the likelihood of exerting a sustained influence on the research field. Key requirements include maintaining active registrations in SAM.gov, eRA Commons, and Grants.gov, as well as adhering to strict cybersecurity incident reporting and human subject protection protocols. The project requires a minimum effort of 3.6 person months per year for the PD/PI and mandates participation in a kick-off meeting in Bethesda, Maryland, and bi-annual steering meetings. Applications must follow specific page limits for the research strategy subsections and include detailed plans for clinical trial implementation, data management, and biorepository services.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

in 3 months
View Details
NAICS: 541714
New
Federal
Pre-Award Synopsis Texas Shield
Solicitation # DARPA-SN-27-07
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), intends to enter into an agreement with The University of Texas System consortium of universities for the Texas Shield Program. This integrated research initiative, identified by solicitation number DARPA-SN-27-07 and NAICS code 541714, focuses on developing autonomous and semi-autonomous medical technologies and scalable solutions for critical medical consumables. The primary goal is to support lifesaving medical care in contested, austere, and resource-limited environments. Key technical areas of focus include autonomous medical and robotic surgical systems, casualty evacuation, artificial-blood and supply innovation, AI-enabled clinical decision support, and mass-casualty science and simulation. This notice is a pre-award synopsis and is not a request for proposals or a competitive solicitation. Interested entities are invited to submit information by November 15, 2026, to TexasShieldxBTO@darpa.mil detailing their technical expertise, integrated research infrastructure, clinical-validation capabilities, and multi-institutional coordination capacity. Additionally, respondents must describe their consortium organizational structure, commercialization capabilities, facility clearance levels, and their ability to handle Controlled Unclassified Information. The government will not reimburse any costs associated with the preparation or submission of information in response to this notice.
Defense Advanced Research Projects Agcy

POSTED

5 days ago

DEADLINE

in 25 days
View Details
NAICS: 541714
New
Federal
Q--AMPLICON SEQUENCING SERVICES
Solicitation # 140G0226Q0047
Solicitation 140G0226Q0047 is a firm-fixed-price request for a Blanket Purchase Agreement (BPA) to provide next generation amplicon sequencing services for the USGS Upper Midwest Water Science Center’s Michigan Bacteriological Research Laboratory. The scope of work includes providing all equipment, labor, travel, and materials necessary to support research on bacterial pathogens, harmful algal blooms, microbial ecology, antibiotic resistance, and microbial source tracking. Key technical requirements include the use of Illumina MiSeq or AVITI sequencing technologies and the potential for library preparation for 16S V4 amplicon sequencing. The BPA has a total not-to-exceed value of 250,000 dollars with an estimated period of performance from September 17, 2026, to September 16, 2031. The award process prioritizes non-priced factors significantly over cost, focusing on the offeror's qualifications and technical performance. Evaluation criteria include a detailed listing of on-site equipment and calibration dates, personnel experience, internal quality assurance procedures, and a technical narrative not exceeding two pages. Performance will be executed in Lansing, Michigan, with delivery terms set as FOB Destination. Administrative requirements include electronic invoicing via the Internet Payment Platform and compliance with various federal regulations, including the Buy American Act and specific security prohibitions regarding telecommunications equipment. Proposals must be submitted to the USGS OAG Denver Acquisition Branch by September 11, 2026.
Ofc Of Acquisition Grants-Denver

POSTED

5 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Defense → W6QK Acc-Pica

Same awarding agency

NAICS: 541511
Federal
Software Integration and Interoperability ServicesThe contract awards services to maintain and enhance associative interfaces between ABAQUS and leading third-party CAD tools including Pro/ENGINEER, CATIA, and Wave6, ensuring seamless data exchange and workflow integration for engineering simulation users. The work focuses on sustaining existing interoperability capabilities while advancing functionality to support evolving software versions and user requirements, with an emphasis on reliability, performance, and user experience across multi-platform environments. This effort supports defense-related engineering workflows by bridging design and analysis ecosystems critical to product development and simulation fidelity. The contract is classified as a subcontract under NAICS code 541511 for custom computer programming services, issued by the Department of Defense through its W6QK Acc-Pica agency, with performance required in Waltham, Massachusetts, 02451. Although details such as solicitation numbers and point of contact are not provided, the posting date of May 14, 2026 indicates the agreement is anticipated to commence following a future competitive process. The scope demands deep technical expertise in CAE software architecture, API development, and cross-platform integration to ensure continued compatibility and functionality between industry-standard design tools and ABAQUS simulation solutions.
Custom Computer Programming Services

POSTED

5 months ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS